Endoscopy in GERD: Boondoggle, diagnostic test, or risk management tool?

American Journal of Gastroenterology

Volumn 103, Issue 2, 2008, Pages 276-278

  Vakil, Nimish ^a,b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b MARQUETTE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

BARRETT ESOPHAGUS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; EMPIRICAL RESEARCH; ENDOSCOPY; GASTROESOPHAGEAL REFLUX; HUMAN; PRIORITY JOURNAL; REVIEW; RISK MANAGEMENT; SYMPTOMATOLOGY;

ENDOSCOPY; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HUMANS; RISK MANAGEMENT;

EID: 39049149443     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2007.01654.x     Document Type: Review

References (17)

1. Vakil N, van Zanten S, Kahrilas P, et al. The Montreal definition and classification of gastro-esophageal reflux disease: A global evidence-based consensus. Am J Gastroenterol 2006 101 : 1900 20.
2. Locke GR 3rd., Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: A population-based study in Olmsted County, Minnesota. Gastroenterology 1997 112 : 1448 56.
3. Corder AP, Jones RH, Sadler GH, et al. Heartburn, oesophagities and Barrett's oesophagus in self-medicating patients in general practice. Br J Clin Pract 1996 50 : 245 8.
4. Johnsson F, Joelsson B, Gudmundsson K, et al. Symptoms and endoscopic findings in the diagnosis of gastro-oesophageal reflux disease. Scand J Gastroentereol 1987 22 : 714 8.
5. Jones RH, Hungin AD, Phillips J, et al. Gastro-oesophageal reflux disease in primary care in Europe: Clinical presentation and endoscopic findings. Eur J Gen Pract 1995 1 : 149 54.
6. Venables TL, Newland RD, Patel AC, et al. Omeprazole 10 milligrams once daily, omeprazole 20 milligrams once daily, or ranitidine 150 milligrams twice daily, evaluated as initial therapy for the relief of gastro-oesophageal reflux disease in general practice. Scand J Gastroenterol 1997 32 : 965 73.
7. Wiklund I, Bordhan KD, Muller-Lissner S, et al. Quality of life during acute and intermittent treatment of gastroesophageal reflux disease with omeprazole compared with ranitidine. Results from a multi-center clinical trial. Gastroenterol Hepatol 1998 30 : 19 27.
8. Vakil N. Pretreatment endoscopy - pro & contra: Is endoscopy needed before treatment in all patients with gastroesophageal reflux disease? Endoscopy 2006 38 : 276 8.
9. Vakil N. Test or treat or treat and test in reflux disease? Aliment Pharmacol Ther 2003 17 (Suppl 2 57 9.
10. Giannini E, Zentilin P, Dulbecco P, et al. Management strategy for patients with gastro-esophageal reflux disease: A comparison between empirical treatment with esomeprazole and endoscopy-oriented treatment. Am J Gastroenterol 2007 xx.
11. Bollschweiler E, Wolfgarten E, Gutschow C, et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males. Cancer 2001 92 : 549 55.
12. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999 340 : 825 31.
13. Lagergren J, Ye W, Bergstrom R, et al. Utility of endoscopic screening for upper gastrointestinal adenocarcinoma. JAMA 2000 284 : 961 2.
14. Inadomi J, Sampliner R, Lagergren J, et al. Cost-effectiveness of screening for Barrett esophagus in high-risk groups, screening and surveillance in high risk groups. A cost-utility analysis. Ann Intern Med 2003 138 : 176 86.
15. Thomson AB, Barkun AN, Armstrong D, et al. The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: The Canadian Adult Dyspepsia Empiric Treatment - Prompt Endoscopy (CADET-PE) study. Aliment Pharmacol Ther 2003 17 : 1481 91.
16. Vakil N, Moayyedi P, Fennerty MB, et al. Limited value of alarm features in the diagnosis of upper gastrointestinal malignancy: Systematic review and meta-analysis. Gastroenterology 2006 131 : 390 401.
17. Quadri A, Vakil N. Health-related anxiety and the effect of open-access endoscopy in US patients with dyspepsia. Aliment Pharmacol Ther 2003 17 : 835 40.